A recruitment SLA should make the next action visible before patient interest goes stale. It needs timing targets, ownership, blocker categories, and escalation rules that fit the study workflow.
In this guide
Key points
- Define response, prescreen review, records request, scheduling, and stale-lead review targets separately.
- Track the reason a patient is waiting instead of only tracking age in queue.
- Escalate blockers that require sponsor, study-team, or site-lead decisions.
Response time is only the first SLA
Fast first follow-up matters, but it is not the whole workflow. A patient can be contacted quickly and still stall because prescreen review, records collection, scheduling, or criteria clarification has no clear owner.
A practical SLA breaks the workflow into stages so the team can see which part is waiting.
Set stage-specific targets
Common stages include new inquiry review, first outreach, prescreen completion, coordinator review, records request, records received, ready to schedule, scheduled screening visit, and stale-lead review.
Each stage should have an owner, a reasonable timing target, and a close reason for patients who should not continue. The point is to prevent silent aging, not to force every patient through the same path.
Track blocker reason alongside age
Age in queue tells the team that something is waiting. Blocker reason tells the team what to do about it. No response, missing records, pending review, scheduling conflict, source mismatch, and criteria question require different actions.
That distinction is what makes an SLA useful in a real recruiting operation.
Define escalation without creating noise
Escalation should be reserved for blockers that need a decision: repeated records friction, unclear criteria language, visit capacity issues, low source quality, or a coordinator queue that is consistently over capacity.
A good escalation note names the blocker, the affected study or site, the owner, and the decision needed by the next reporting cycle.
Review the SLA weekly
The SLA should be reviewed with the actual recruiting queue. Which patients moved, which stalled, what reasons repeated, and what changed after last week's actions?
That review keeps the SLA grounded in patient momentum rather than turning it into a static policy document.
Sources and editorial notes
Published .
This guide explains recruitment work and questions to discuss with your team.
This information is educational. Your study team makes medical, eligibility, and enrollment decisions.
See TrialsNest in action
Bring this workflow into one place.
Manage inquiries, follow-ups, records, and visits. Keep sponsors updated on progress.
Coordinator Today
Your inquiries, priorities, and upcoming visits.
- Inquiries assigned
- 14 3 pending review
- Visits today
- 6 4 in person · 2 virtual
- Action priorities
- 4 Needs attention
- Active studies
- 3 Study A · B · C
Priority tasks
- Review screening intakeInquiry 001 · Study ACompleted
- Verify specimen preparationStudy A · Due 10:00 AMCompleted
- Confirm visit windowInquiry 003 · Follow-upPending
Upcoming visits
- In personInquiry 001
Study A · Baseline visit
View visit details → - TelehealthInquiry 003
Study A · Prescreen
Review appointment → - In personInquiry 004
Study B · Week 4
View visit details →
Keep reading
Clinical trial recruitment dashboard weekly review template
A practical weekly review template for clinical trial recruitment dashboards covering movement, stale leads, source quality, records readiness, scheduling, and next-action ownership.
Clinical trial recruitment software for multi-site studies
A guide to recruitment software for multi-site studies, covering shared workflow standards, local queues, source quality, scheduling, and reporting.
Site recruitment workflow for clinical trials
See the site recruitment workflow for clinical trials, from patient intake and records readiness to patient recruitment tracking dashboards, scheduling, and sponsor updates.
How a research site can reduce stale recruitment leads: example workflow
Stale leads are often a workflow problem, not only a patient-interest problem. The fix starts with naming why the lead stalled.
